HealthTree

Your Feed

Filter by

See content from

Back to the latest

New CLL Discovery: Deletion of MGA Gene and Richter's Transformation

New CLL Discovery: Deletion of MGA Gene and Richter's Transformation image

Thumbnail for Addressing Racial and Ethnic Disparities in AML Clinical Trials | Andrew Hantel, MD | ASH 2023

Playlist: ASH 2023

Addressing Racial and Ethnic Disparities in AML Clinical Trials | Andrew Hantel, MD | ASH 2023

Video details & playlist

Thumbnail for Study on Minimizing Exclusion for AML Patients in Clinical Trials | Andrew Hantel, MD | ASH 2023

Playlist: ASH 2023

Study on Minimizing Exclusion for AML Patients in Clinical Trials | Andrew Hantel, MD | ASH 2023

Video details & playlist

Thumbnail for Results from Venetoclax Added to CLAD Combo for Older Patients With AML | Tapan Kadia, MD | ASH 2023

Playlist: ASH 2023

Results from Venetoclax Added to CLAD Combo for Older Patients With AML | Tapan Kadia, MD | ASH 2023

Video details & playlist

Thumbnail for Costs of Venetoclax-Obinutuzumab vs. BTKi in CLL | Scott Huntington, MD, MPH, MSc | ASH 2023

Playlist: ASH 2023

Costs of Venetoclax-Obinutuzumab vs. BTKi in CLL | Scott Huntington, MD, MPH, MSc | ASH 2023

Video details & playlist

Thumbnail for Moving to a Fully Oral Drug Combination for Older/Frail AML Patients | Tapan Kadia, MD | ASH 2023

Playlist: ASH 2023

Moving to a Fully Oral Drug Combination for Older/Frail AML Patients | Tapan Kadia, MD | ASH 2023

Video details & playlist

Thumbnail for Extending AML Remissions with Hypomethylating Agents and Venetoclax | Tapan Kadia, MD | ASH 2023

Playlist: ASH 2023

Extending AML Remissions with Hypomethylating Agents and Venetoclax | Tapan Kadia, MD | ASH 2023

Video details & playlist

ASH 2023: Cost of Venetoclax + Obinutuzumab vs BTK Inhibitors for First-time Treated CLL Patients on Medicare

ASH 2023: Cost of Venetoclax + Obinutuzumab vs BTK Inhibitors for First-time Treated CLL Patients on Medicare image

Pirtobrutinib (Jaypirca) Now FDA Approved for Previously-treated CLL

Pirtobrutinib (Jaypirca) Now FDA Approved for Previously-treated CLL image

Mindfulness Technique for CLL Patients: Wise Mind

Mindfulness Technique for CLL Patients: Wise Mind image

Recipes for CLL Patients: Balsamic Glazed Sweet Potato Fries

Recipes for CLL Patients: Balsamic Glazed Sweet Potato Fries image

My Loved One Has Passed Away. Where Do I Go From Here? image

My Loved One Has Passed Away. Where Do I Go From Here?

02:00PM - 03:00PM EST

Watch Recording

The Gift of Life, Alan's Story

The Gift of Life, Alan's Story image

High Copper and Low Zinc Consumption Disrupt p53 Function

High Copper and Low Zinc Consumption Disrupt p53 Function image

Caring for the Caregiver

Caring for the Caregiver image

The Role of a Financial Advisor and How to Choose One

The Role of a Financial Advisor and How to Choose One image

Recapping the HealthTree 2.0 Launch

Recapping the HealthTree 2.0 Launch image

Tests for CLL Patients: Quantitative Immunoglobulins

Tests for CLL Patients: Quantitative Immunoglobulins image

Infection Prevention for AML Patients

Infection Prevention for AML Patients image

New CLL Discovery: Small Molecule FL3 Effect on CLL Cells

New CLL Discovery: Small Molecule FL3 Effect on CLL Cells image

Acute Promyelocytic Leukemia: A Subtype of AML

Acute Promyelocytic Leukemia: A Subtype of AML image

AML Survivorship: Challenges and Opportunities

AML Survivorship: Challenges and Opportunities image

Palliative Care and Hospice for CLL Patients

Palliative Care and Hospice for CLL Patients image

Janice’s CLL Treatment Experience with Venclexta + Gazyva

Janice’s CLL Treatment Experience with Venclexta + Gazyva image

More from HealthTree